Genetic testing, counseling and support for individuals and families at risk for hereditary cancer
The center for Cancer Risk assessment
Information by disease clinic
The majority of cancers that are diagnosed are considered sporadic and are not primarily due to an inherited factor. Individuals can develop sporadic cancer due to chance events, environmental exposures, or certain lifestyle factors. However, in 5-10% of cancer cases, inherited factors (genes), contribute to the development of certain types of cancer in a family. At the Center for Cancer Risk Assessment (CCRA), our team helps to identify families that may have a hereditary cancer syndrome and offer appropriate testing and/or screening. In each of the CCRA clinics, our genetic counselors offer hereditary cancer risk assessment, education, and genetic testing, when indicated. This information may be useful in managing a person’s risk to develop cancer. On the research side, the CCRA aims to integrate molecular genetics and the clinical study of cancer predisposition to further the understanding of hereditary cancer syndromes.
The Center for Cancer Risk Assessment Team
Director
Administrative Director
Scientific Director
Clinical Directors
- Leif Ellisen, MD, PhD
Breast and Ovarian Cancer Genetics and Risk Assessment Program - Daniel C. Chung, MD
Gastrointestinal Cancer Genetics Program - Othon Iliopoulos, MD
Von Hippel-Lindau Syndrome/Familial Renal Cell Program - Hensin Tsao, MD, PhD
Melanoma Genetics Program - Giuseppe Barbesino, MD
Gilbert H. Daniels, MD
Endocrine Tumor Genetics Program
Program Physicians
- Andrew T. Chan, MD
Gastroenterologist - David McFadden, MD, PhD
Endocrinologist - Nikolaos Stathatos, MD
Endocrinologist - Douglas S. Ross, MD
Endocrinologist
Program Manager
- Kristen Mahoney Shannon, MS, CGC
Senior Genetic Counselor
Genetics Counselors
